Skip to main content
Log in

Sexualität bei Übergewicht und Adipositas

Sexuality in overweight and obesity

  • themenschwerpunkt
  • Published:
Wiener Medizinische Wochenschrift Aims and scope Submit manuscript

Zusammenfassung

Die Assoziation zwischen Adipositas und Sexualfunktionsstörungen ist in vielen Studien beschrieben. Neurobiologische, hormonelle und vaskuläre Störungen sowie psychische Erkrankungen gelten bei beiden Geschlechtern als Hauptursachen. Sexuelles Interesse und Verlangen, sexuelle Erregung, Orgasmus, schmerzhafter Geschlechtsverkehr und Ejakulation können betroffen sein. Die Datenlage zu Prävalenzzahlen für Sexualfunktionsstörungen bei adipösen Menschen ist aufgrund der Studien mit kleinen Fallzahlen beschränkt. Für das Screening von Sexualfunktionsstörungen stehen zwei validierte Scores zur Verfügung. Der Internationale Index of Erectile Function-5 (IIEF5), der 15 Fragen enthält und der Female Sexual Function Index (FSFI), der 19 Fragen enthält sind multidimensionale und validierte diagnostische Methoden für das jeweilige Geschlecht. Die Behandlung umfasst Lebensstilveränderungen mit vermehrter körperlicher Aktivität, Gewichtskontrolle, gesunde Ernährung und Beendigung von Tabakkonsum. Testosteron Substitution in Fällen eines nachgewiesenen Hypogonadismus und Therapie mit PDE-5 Inhibitoren sind gut dokumentierte Behandlungsoptionen bei Männern. Therapieoptionen für Frauen sind nicht so gut evaluiert, wobei Fibanserin, Testosteron, Bupropion und Oxytocin wirksam sein dürften.

Summary

The association between obesity and sexual dysfunction has been described in many studies. Neurobiological, hormonal, vascular and mental disturbances are the main reasons in male and in female gender. Sexual interest and desire, sexual arousal, orgasm, painful intercourse and premature ejaculation can be involved. Data for prevalence of sexual function disturbances in obese people are scarce and most studies were small. For screening of sexual function we recommend the International Index of Erectile Function (IIEF)-Score, which contains 15 Items for males and the Female Sexual Function Index (FSFI), which contains 19 items for females. Treatment of sexual function disturbances include lifestyle changes with an increase of physical activity, weight control, healthy eating and smoking cessation. Testosterone substitution in cases of real hypogonadism and treatment with PDE-5 inhibitors are well documented treatment options in male individuals. New treatment options for female patients with variable effectiveness are fibanserin, testosterone, bupropione and oxytocin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Kolotkin RL, Zunker C, Ostbye T. Sexual functioning and obesity: a review. Obesity (Silver Spring). 2012;20(12):2325–33.

    Article  Google Scholar 

  2. Lewis RW, Fugl-Meyer KS, Corona G, et al. Definitions/epidemiology/risk factors for sexual dysfunction. J Sex Med. 2010;7:1598–607.

    Article  PubMed  Google Scholar 

  3. Laumann EO, Glasser DB, Neves RC, Moreira ED, GSSAB Investigators Group. A population-based survey of sexual activity, sexual problems and associated help-seeking behaviour patterns in mature adults in the United States of America. Int J Impot Res. 2009;21(3):171–8.

    Article  CAS  PubMed  Google Scholar 

  4. Bond DS, Wing RR, Sivamainthan V, et al. Significant resolution of female sexual dysfunction after bariatric surgery. Surg Obes Realt Dis. 2011;7(1):1–7.

    Article  Google Scholar 

  5. Bajos N, Wellings K, Laborde C, Moreau C, CSF Group. Sexuality and obesity, a gender perspective: results from French national random probability survey of sexual behaviours. BMJ 2010;340:c2573.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Dhinsda S, Miller MG, Whirter CL, et al. Testosterone concentrations in diabetic and non diabetic obese men. Diabetes Care. 2010;33:1186–92.

    Article  Google Scholar 

  7. Han TS, Tajar A, O’Neill TW, et al. Impaired quality of life and sexual function in overweight and obese men: the European Male Ageing Study. Eur J Endocrinol. 2011;164:1003–11.

    Article  CAS  PubMed  Google Scholar 

  8. Bhasin Sh, Enzlin P, Covielleo A, Basson R. Sexual dysfunction in men and women with endocrine disorders. Lancet. 2007;369:597–609.

    Article  CAS  PubMed  Google Scholar 

  9. Kinzl JF, Trefalt E, Fiala M, Hotter A, Biebl W, Aigner F. Partnership, sexuality, and sexual disorders in morbidly obese women: consequences of weight loss after gastric banding. Obesity Surg. 2001;11(4):455–8.

    Article  CAS  Google Scholar 

  10. Puhl RM, Brownell KD. Confronting and Coping with weight stigma: an investigation of overweight and obese adults. Obesity (Silver Spring). 2006;14(10):1802–15.

    Article  Google Scholar 

  11. Esposito K, Giugliano F, Ciotola M, De Sio M, DÀrmiento M, Giugliano D. Obesity and sexual dysfunction, male and female. Int J Impot Res. 2008;20:358–65.

    Article  CAS  PubMed  Google Scholar 

  12. Pastuszak AW, Badhiwala N, Lipshultz LI, Khera M. Depression is correlated with the psychological and physical aspects of sexual dysfunction in men. Int J Impot Res. 2013;25:194–9.

    Article  CAS  PubMed  Google Scholar 

  13. Harte CB, Meston CM. Association between smoking cessation and sexual health in men. BJU. 2012;109(6):888–96.

    Article  Google Scholar 

  14. Cheng JYW, NG EML, Chen RYL. Physical activity and erectile dysfunction: meta-analysis of population –based studies. Int J Impot Res. 2007;19:245–52.

    Article  CAS  PubMed  Google Scholar 

  15. Katz A. Couples and cancer. Oncol Nurs Forum. 2013;40(2):105.

    Article  PubMed  Google Scholar 

  16. Rosen R, Riley A, Wagner G, et al. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822–30.

    Article  CAS  PubMed  Google Scholar 

  17. Wiegel M, Meston C, Rosen R. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 2005;31(1):1–20.

    Article  PubMed  Google Scholar 

  18. Dandona P, Dhinsda S. Update: hypogonadotropic hypogonadism in type 2 diabetes and obesity. J Clin Endocrinol Metab. 2011;96:2634–51.

    Google Scholar 

  19. Isidori AM, Giannetta E, Lenzi A. Male hypogonadism. Pituitary. 2008;11(2):171–80.

    Article  PubMed  Google Scholar 

  20. Mogri M, Dhinsda S, Quattrin T, Ghanim H, Dandona P. Testosterone concentrations in young pubertal and post-pubertal obese males. Clin Endocrinol (Oxf). 2012;78:593–9.

    Article  Google Scholar 

  21. Giagulli VA, Kaufmann JM, Vermeulen A. Pathogenesis of the decreased androgen levels in obese men. J Clin Endocrinol Metab. 1994;79:997–100.

    CAS  PubMed  Google Scholar 

  22. Vermeulen A, Goemaere S, Kaufmann JM. Testosterone body composition and aging. J Endocrinol Invest. 1999;22 Suppl 5:110–6.

    CAS  PubMed  Google Scholar 

  23. Esposito K, Ciotola M, Giugliano F, et al. Association of body weight with sexual function in woman. Int J Impot Res. 2007;19:353–7.

    Article  CAS  PubMed  Google Scholar 

  24. Morotti E, Battaglia B, Paradisi R, et al. Body mass index, stunkard figure rating scale, and sexuality in young italian women: a pilot study. J Sex Med. 2013;10(4):1034–43.

    Article  PubMed  Google Scholar 

  25. Basson R. Sexual desire and arousal disorders in women. N Engl J Med. 2006;354:1497–506.

    Article  CAS  PubMed  Google Scholar 

  26. Corona G, Ricca V, Bandini E, et al. Selective serotonin reuptake inhibitor-induced sexual dysfunction. J Sex Med. 2009;6(5):1259–69.

    Article  CAS  PubMed  Google Scholar 

  27. Bond DS, Vithiananthan S, Leahey TM, et al. Prevalence and degree of sexual dysfunction in a sample of women seeking bariatric surgery. Surg Obes Relat Dis. 2009;5(6):698–704.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Nicolai MPJ, Liem SS, Both S, et al. A review of the positive and negative effects of cardiovascular drugs on sexual function: a proposed table for use in clinical practice. Neth Heart J. 2014;22:11–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Hartmann U. Depression and sexual dysfunction: aspects of a multi-faceted relationship. Psychiatr Prax. 2007;34 Suppl 3:314–17.

    Article  Google Scholar 

  30. Schreiner-Engel P, Schiavi RC. Lifetime psychopathology in individuals with low sexual desire. J Nerv Ment Dis. 1986;174:646–51.

    Article  CAS  PubMed  Google Scholar 

  31. Gregorian RS, Golden KA, Bahce A, Goodman C, Kwong WJ, Khan ZM. Antidepressant-induced sexual dysfunction. Annal Pharmacother. 2002;36:1577–89.

    Article  CAS  Google Scholar 

  32. Zajecka J. Strategies for the treatment of antidepressant-induced sexual dysfunction. J Clin Psychiatry. 2001;23:1040–58.

    Google Scholar 

  33. Kinzl JF, Schrattenecker M, Traweger C, Aigner F, Fiala M, Biebl W. Quality of life in morbidly obese patients after surgical weight loss. Obes Surg. 2007;17(2):229–35.

    Article  PubMed  Google Scholar 

  34. Kinzl JF, Trefalt E, Fiala M, Hotter A, Biebl W, Aigner F. Partnership, sexuality, and sexual disorders in morbidly obese women: consequences of weight loss after gastric banding. Obes Surg 2001;11(4):455–8.

    Article  CAS  PubMed  Google Scholar 

  35. Heidler S, Temml C, Broessner C, et al. Is the metabolic syndrome an independent risk factor for erectile dysfunction? J Urol. 2007;177(2):651–4.

    Article  PubMed  Google Scholar 

  36. Ponholzer A, Temml C, Mock K, Marszalek M, Obermayr R, Madersbacher S. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol. 2005;47:80–6.

    Article  PubMed  Google Scholar 

  37. Ponholzer A, Roehlich M, Racz U, Temml C, Madersbacher S. Female sexual dysfunction in a healthy Austrian vohort: prevalence and risk factors. Eur Urol. 2005;47(3):366–74.

    Article  PubMed  Google Scholar 

  38. Esposito K, Giugliano F, Di Palo C, et al. Effect of lifestyle changes on erectile dysfunction in obese men. JAMA. 2004;291:2978–84.

    Article  CAS  PubMed  Google Scholar 

  39. Hammoud A, Gibson M, Hunt SC, et al. Effect of Roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men. J Clin Endocrinol Metab. 2009;94(4):1329–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Basson R, Brotto LA. Sexual psychophysiology and effects of sildenafil citrate in oestrogenised women with acquired genital arousal disorder and impaired orgasm: a randomised controlled trial. BJOG. 2003;110:1014–24.

    Article  CAS  PubMed  Google Scholar 

  41. Basson R, McInnes R, Smith MD, Hodgson G, Koppiker N. Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal. J Womens Health Gend Based Med. 2002;11:367–77.

    Article  PubMed  Google Scholar 

  42. Simon JA, Kingsberg SA, Shumel B, et al. Efficacy and safety of fibanserin in postmeopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial. Menopause. 2014;21:633.

    Article  PubMed  Google Scholar 

  43. Safarinejad MR, Hosseini SY, Asgari MA, et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of bupropion for treating hypoactive sexual desire disorder in ovulating women. BJU Int. 2010;106:832.

    Article  CAS  PubMed  Google Scholar 

  44. Muin DA, Woltz M, Marculescu R, et al. Effect of long-term intranasal oxytocin on sexual dysfunction in premenopausal and postmenopausal women: a randomized trial. Fertil Steril. 2015;104(3):715–23.

    Article  CAS  PubMed  Google Scholar 

  45. Günzler C, Berner MM. Efficacy of psychosocial interventions in men and women with sexual dysfunctions – a systematic review of controlled clinical trials: part2 – the efficacy of psychosocial interventions for female sexual dysfunction. J Sex Med. 2012;9(12):3108–25.

    Article  PubMed  Google Scholar 

  46. Berner M, Günzler C. Efficacy of psychosocial interventions in men and women with sexual dysfunctions – a systematic review of controlled clinical trials: part1 – the efficacy of psychosocial interventions for male sexual dysfunction. J Sex Med. 2012;9(12):3089–107.

    Article  PubMed  Google Scholar 

  47. Nehra A, Jackson G, Miner M, et al. The Princeton III consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012;87(8):766–78.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Poggiogalle E, Lazzaro L, Pinto A, Migliaccio S, Lenzi A, Donini LM. Health-related quality of life and quality of sexual life in obese subjects. Int J Endocrinol. 2014;2014:847871. doi:10.1155/2014/847871.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Danksagung

Wir danken A Ponholzer und E Bragnana für die Unterstützung bei der Erstellung dieses Beitrages.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Heidemarie Abrahamian.

Ethics declarations

Interessenkonflikt

H. Abrahamian und A. Kautzky-Willer geben an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abrahamian, H., Kautzky-Willer, A. Sexualität bei Übergewicht und Adipositas. Wien Med Wochenschr 166, 121–128 (2016). https://doi.org/10.1007/s10354-016-0430-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10354-016-0430-9

Schlüsselwörter

Keywords

Navigation